RESUMEN
We aimed to determine the prevalence of hepatitis B surface antigen (HBsAg) among chronic schizophrenia patients in Jordan. Over a period of 12 months, 192 patients (106 male and 86 female) were tested for hepatitis B virus (HBV) by enzyme immunoassay. An equal number of age- and sex-matched healthy controls was also tested. Of the schizophrenia patients, 14 (10 male and 4 female) were positive for HBsAg while only 5 (4 male and 1 female) of the control subjects tested positive. The difference was not statistically significant but it indicates that chronic schizophrenia patients are a risk group for HBV infection and likely to benefit from preventive measures (health education and immunization against HBV).
Asunto(s)
Hepatitis B/epidemiología , Hepatitis B/etiología , Esquizofrenia/complicaciones , Adolescente , Adulto , Distribución por Edad , Estudios de Casos y Controles , Enfermedad Crónica , Femenino , Hepatitis B/sangre , Hepatitis B/inmunología , Hepatitis B/prevención & control , Antígenos de Superficie de la Hepatitis B/sangre , Humanos , Jordania , Masculino , Persona de Mediana Edad , Admisión del Paciente/estadística & datos numéricos , Vigilancia de la Población , Estudios Prospectivos , Factores de Riesgo , Estudios Seroepidemiológicos , Distribución por Sexo , Factores de TiempoRESUMEN
We aimed to determine the prevalence of hepatitis B surface antigen [HBsAg] among chronic schizophrenia patients in Jordan. Over a period of 12 months, 192 patients [106 male and 86 female] were tested for hepatitis B virus [HBV] by enzyme immunoassay. An equal number of age- and sex-matched healthy controls was also tested. Of the schizophrenia patients, 14 [10 male and 4 female] were positive for HBsAg while only 5 [4 male and 1 female] of the control subjects tested positive. The difference was not statistically significant but it indicates that chronic schizophrenia patients are a risk group for HBV infection and likely to benefit from preventive measures [health education and immunization against HBV]